Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma

Clinical trial NCT00204555 · COMPLETED

Trial details

NCT number: NCT00204555
Sponsor: University Hospital Tuebingen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Carcinoma, Basal Cell

Start date: 2002-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.